CMDInventusSM
CMD Bioscience introduces its peptide research and discovery platform: CMDInventusSM

CMDInventusSM our computational biotechnology platform provides a powerful and elegant solution to the problem of novel peptide discovery and design. Our computational biotechnology platform has been designed from the ground up to minimize risk and facilitate computational peptide drug design. 

​CMDInventusSM incorporates our proprietary work-flow for analyzing, modeling and optimizing protein and peptide structures, our de novo peptide ligand design algorithm, our proprietary peptide docking and virtual screening work-flows.

CMDSolvationSM is our cutting-edge computational method for predicting the water-membrane partitioning behavior of peptides and proteins. This is a key capability for successful peptide discovery. 

In sum, our scoring methodologies, our phase partitioning function, our docking and virtual screening underpin CMDInventusSM our peptide drug discovery computational platform for Peptide Research.
Accelerating Peptide Discovery
HomePlatform TechnologyOur ServicesNews & EventsAbout UsPartnershipsContact UsCMD Blog

Copyright 2012: CMD Bioscience. Computational Biotechnology. All rights reserved.
5 Science Park New Haven, CT 06511 203-298-4251 | info@cmdbioscience.com
The core modules of CMDInventusSM are the fast, hierarchical, physics-based, and proprietary scoring methodologies for predicting and rationalizing protein-protein and protein-peptide binding affinities.

CMDeScore and CMDmScore scoring methodolgies have been rigorously validated against numerous large and diverse test sets. A fair summary of the testing performed indicates that our methodologies can be used to accurately estimate experimental binding free energies within ≈ 1.0 kcal, with ≈ 85% success rate.

CMDeScore and CMDmScore methodologies outperform comparable approaches and represents a significant step forward in the science of protein-protein and protein-peptide binding affinity prediction. 

CMDInventusSM core module methodologies are computationally inexpensive, fast, and suitable for solving structure-based design problems of protein-peptide interactions and is well-suited to serve as the primary scoring function for a peptide drug discovery platform.

CMDInventusSM Core Modules are a computational game changer.